Symbols / ARAY $0.47 +11.00% Accuray Incorporated

Healthcare • Medical Devices • United States • NMS
ARAY Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Fundamentals
Scroll to Statements
Market Cap 55.52M Enterprise Value 182.95M Income -35.62M Sales 436.97M Book/sh 0.45 Cash/sh 0.35
Dividend Yield — Payout 0.00% Employees 990 IPO — P/E — Forward P/E -15.58
PEG 29.49 P/S 0.13 P/B 1.04 P/C — EV/EBITDA -107.62 EV/Sales 0.42
Quick Ratio 0.60 Current Ratio 1.47 Debt/Eq 326.14 LT Debt/Eq — EPS (ttm) -0.31 EPS next Y -0.03
EPS Growth — Revenue Growth -12.00% Earnings 2026-05-06 ROA -1.18% ROE -70.32% ROIC —
Gross Margin 27.85% Oper. Margin -5.37% Profit Margin -8.15% Shs Outstand 118.78M Shs Float 112.94M Short Float 7.35%
Short Ratio 5.00 Short Interest — 52W High 2.10 52W Low 0.33 Beta 1.32 Avg Volume 1.32M
Volume 718.63K Target Price $2.52 Recom Strong_buy Prev Close $0.42 Price $0.47 Change 11.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$2.53
Mean price target
2. Current target
$0.47
Latest analyst target
3. DCF / Fair value
$-0.12
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.47
Low
$2.00
High
$3.05
Mean
$2.53

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-05 main BTIG Buy → Buy $2
2025-11-06 main BTIG Buy → Buy $4
2025-08-14 main BTIG Buy → Buy $5
2024-02-13 init Roth MKM — → Buy $9
2023-10-04 reit B. Riley Securities Buy → Buy $8
2022-06-24 main BTIG — → Buy $7
2022-06-23 init B. Riley Securities — → Buy $8
2021-12-22 init Loop Capital — → Buy $8
2020-01-21 up BTIG Neutral → Buy —
2018-11-01 up Citigroup Sell → Neutral $4
2018-08-17 main Citigroup Sell → Sell $4
2017-12-13 down JP Morgan Neutral → Underweight —
2017-11-30 init Lake Street — → Buy $10
2017-08-23 main Jefferies — → Buy $6
2017-02-06 init Aegis Capital — → Buy —
2016-12-14 down JP Morgan Overweight → Neutral $6
2016-09-13 init Cowen & Co. — → Outperform —
2015-12-22 init RBC Capital — → Sector Perform $8
2015-11-12 init Citigroup — → Sell $6
2015-01-12 init Northland Capital Markets — → Outperform $11
News
RSS: Latest ARAY news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-27 PERALTA LEONEL Chief Operating Officer — 83,723 — —
2026-02-20 MAYER STEVEN F Director — 54,875 $0.56 $30,878
2026-02-19 MAYER STEVEN F Director — 195,125 $0.53 $103,797
2025-12-31 SCOTT BYRON C Director — 9,433 — —
2025-11-28 MAYER STEVEN F Director — 895,391 $0.00 $0
2025-11-28 GALBATO CHAN W Director — 50,000 $0.00 $0
2025-11-28 CHALKE SANDEEP Officer — 50,314 — —
2025-11-28 PERVAIZ ALI Chief Financial Officer — 44,025 — —
2025-11-21 WHITTERS JOSEPH E Director — 56,603 — —
2025-11-21 MAYER STEVEN F Director — 45,620 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
458.50
+2.68%
446.55
-0.24%
447.61
+4.12%
429.91
Operating Revenue
458.50
+2.68%
446.55
-0.24%
447.61
+4.12%
429.91
Cost Of Revenue
311.54
+2.60%
303.63
+3.40%
293.64
+8.78%
269.95
Reconciled Cost Of Revenue
311.54
+2.60%
303.63
+3.40%
293.64
+8.78%
269.95
Gross Profit
146.97
+2.83%
142.92
-7.17%
153.96
-3.75%
159.96
Operating Expense
139.13
-2.31%
142.42
-6.04%
151.58
-0.15%
151.81
Research And Development
47.94
-3.60%
49.73
-12.95%
57.13
-1.08%
57.75
Selling General And Administration
91.19
-1.62%
92.69
-1.87%
94.45
+0.42%
94.06
Selling And Marketing Expense
43.31
+1.63%
42.62
-7.71%
46.18
-7.02%
49.66
General And Administrative Expense
47.87
-4.38%
50.07
+3.72%
48.27
+8.74%
44.39
Other Gand A
47.87
-4.38%
50.07
+3.72%
48.27
+8.74%
44.39
Total Expenses
450.67
+1.04%
446.05
+0.19%
445.22
+5.56%
421.76
Operating Income
7.84
+1455.36%
0.50
-78.84%
2.38
-70.77%
8.15
Total Operating Income As Reported
7.84
+1455.36%
0.50
-78.84%
2.38
-70.77%
8.15
EBITDA
20.24
+254.49%
5.71
-31.80%
8.37
-28.08%
11.64
Normalized EBITDA
20.07
+109.75%
9.57
+3.43%
9.25
-35.13%
14.26
Reconciled Depreciation
6.15
+4.15%
5.91
+30.44%
4.53
-17.88%
5.51
EBIT
14.09
+7287.76%
-0.20
-105.10%
3.84
-37.26%
6.13
Total Unusual Items
0.17
+104.49%
-3.86
-339.29%
-0.88
+66.46%
-2.62
Total Unusual Items Excluding Goodwill
0.17
+104.49%
-3.86
-339.29%
-0.88
+66.46%
-2.62
Special Income Charges
1.48
0.00
0.00
0.00
Other Special Charges
-1.48
—
—
—
Net Income
-1.59
+89.77%
-15.54
-67.51%
-9.28
-73.56%
-5.35
Pretax Income
1.13
+109.59%
-11.82
-74.13%
-6.79
-239.06%
-2.00
Net Non Operating Interest Income Expense
-11.76
-13.17%
-10.39
+2.25%
-10.63
-30.79%
-8.13
Interest Expense Non Operating
12.95
+11.44%
11.62
+9.33%
10.63
+30.79%
8.13
Net Interest Income
-11.76
-13.17%
-10.39
+2.25%
-10.63
-30.79%
-8.13
Interest Expense
12.95
+11.44%
11.62
+9.33%
10.63
+30.79%
8.13
Interest Income Non Operating
1.19
-3.17%
1.23
—
—
Interest Income
1.19
-3.17%
1.23
—
—
Other Income Expense
5.06
+361.89%
-1.93
-232.08%
1.46
+172.34%
-2.02
Other Non Operating Income Expenses
0.17
+93.18%
0.09
+137.93%
-0.23
-165.17%
0.36
Gain On Sale Of Security
-1.30
+66.24%
-3.86
-339.29%
-0.88
+66.46%
-2.62
Tax Provision
2.73
-26.85%
3.73
+49.48%
2.49
-25.50%
3.35
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.04
+104.49%
-0.81
-339.29%
-0.18
+66.46%
-0.55
Net Income Including Noncontrolling Interests
-1.59
+89.77%
-15.54
-67.51%
-9.28
-73.56%
-5.35
Net Income From Continuing Operation Net Minority Interest
-1.59
+89.77%
-15.54
-67.51%
-9.28
-73.56%
-5.35
Net Income From Continuing And Discontinued Operation
-1.59
+89.77%
-15.54
-67.51%
-9.28
-73.56%
-5.35
Net Income Continuous Operations
-1.59
+89.77%
-15.54
-67.51%
-9.28
-73.56%
-5.35
Normalized Income
-1.73
+86.18%
-12.50
-45.56%
-8.59
-161.88%
-3.28
Net Income Common Stockholders
-1.59
+89.77%
-15.54
-67.51%
-9.28
-73.56%
-5.35
Diluted EPS
-0.02
+87.50%
-0.16
-60.00%
-0.10
-66.67%
-0.06
Basic EPS
-0.02
+87.50%
-0.16
-60.00%
-0.10
-66.67%
-0.06
Basic Average Shares
102.77
+4.58%
98.27
+3.57%
94.88
+3.03%
92.09
Diluted Average Shares
102.77
+4.58%
98.27
+3.57%
94.88
+3.03%
92.09
Diluted NI Availto Com Stockholders
-1.59
+89.77%
-15.54
-67.51%
-9.28
-73.56%
-5.35
Earnings From Equity Interest
4.71
+156.47%
1.84
-28.54%
2.57
+967.22%
0.24
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Assets
470.24
+0.34%
468.63
-2.21%
479.21
+1.35%
472.85
Current Assets
317.46
-1.79%
323.24
-4.38%
338.03
-3.66%
350.89
Cash Cash Equivalents And Short Term Investments
57.42
-16.27%
68.57
-23.30%
89.40
+0.75%
88.74
Cash And Cash Equivalents
57.42
-16.27%
68.57
-23.30%
89.40
+0.75%
88.74
Receivables
97.87
-1.00%
98.86
+13.24%
87.30
-14.00%
101.50
Accounts Receivable
83.19
-9.57%
92.00
+23.03%
74.78
-20.82%
94.44
Gross Accounts Receivable
83.56
-11.34%
94.25
+21.06%
77.86
-18.43%
95.44
Allowance For Doubtful Accounts Receivable
-0.37
+83.61%
-2.25
+26.89%
-3.08
-207.90%
-1.00
Other Receivables
2.45
-0.28%
2.46
—
13.32
Taxes Receivable
12.22
+178.15%
4.39
-64.90%
12.52
+77.36%
7.06
Inventory
141.02
+1.95%
138.32
-4.70%
145.15
+2.04%
142.25
Raw Materials
49.00
-15.07%
57.70
-8.33%
62.95
+1.74%
61.87
Finished Goods
77.17
+15.19%
67.00
+3.49%
64.74
+1.12%
64.02
Prepaid Assets
9.95
-3.47%
10.31
-11.38%
11.63
+0.48%
11.57
Current Deferred Assets
3.71
+36.13%
2.73
+16.00%
2.35
-22.93%
3.05
Restricted Cash
0.57
+18.35%
0.48
-7.44%
0.52
+156.86%
0.20
Other Current Assets
6.93
+74.53%
3.97
+135.89%
1.68
-52.90%
3.57
Total Non Current Assets
152.77
+5.08%
145.39
+2.98%
141.18
+15.76%
121.96
Net PPE
61.77
+5.51%
58.55
+25.16%
46.78
+58.66%
29.48
Gross PPE
139.68
+5.64%
132.23
+5.50%
125.34
+15.32%
108.69
Accumulated Depreciation
-77.91
-5.74%
-73.68
+6.21%
-78.56
+0.82%
-79.21
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
69.44
+6.97%
64.91
+9.38%
59.35
-4.64%
62.24
Construction In Progress
4.64
+82.00%
2.55
-81.11%
13.50
+350.12%
3.00
Other Properties
33.12
-1.95%
33.77
+30.63%
25.85
+53.91%
16.80
Leases
32.49
+4.83%
30.99
+16.34%
26.64
-0.07%
26.66
Goodwill And Other Intangible Assets
57.82
+0.15%
57.73
-0.28%
57.89
-0.34%
58.09
Goodwill
57.80
+0.23%
57.67
-0.02%
57.68
-0.27%
57.84
Other Intangible Assets
0.01
-74.58%
0.06
-71.90%
0.21
-16.00%
0.25
Investments And Advances
4.61
-53.06%
9.83
-35.05%
15.13
+9.00%
13.88
Long Term Equity Investment
4.61
-53.06%
9.83
-35.05%
15.13
+9.00%
13.88
Non Current Accounts Receivable
3.78
+32.11%
2.86
-39.61%
4.73
-10.70%
5.30
Non Current Deferred Assets
6.12
-27.44%
8.43
-16.60%
10.10
+3.59%
9.75
Non Current Deferred Taxes Assets
0.76
+14.72%
0.66
-23.37%
0.86
—
Other Non Current Assets
18.68
+133.47%
8.00
+22.25%
6.54
+20.05%
5.45
Total Liabilities Net Minority Interest
389.07
-8.14%
423.54
-0.47%
425.56
+1.40%
419.66
Current Liabilities
192.58
-1.38%
195.27
-1.70%
198.64
-4.89%
208.86
Payables And Accrued Expenses
53.68
-18.83%
66.14
+4.49%
63.30
+26.92%
49.87
Payables
47.41
-15.74%
56.27
+18.85%
47.35
+19.69%
39.56
Accounts Payable
34.03
-31.96%
50.02
+48.26%
33.74
+7.67%
31.34
Current Accrued Expenses
6.27
-36.44%
9.86
-38.15%
15.95
+54.66%
10.31
Pensionand Other Post Retirement Benefit Plans Current
14.57
-14.92%
17.13
-28.01%
23.79
-19.18%
29.44
Total Tax Payable
13.38
+113.96%
6.25
-54.05%
13.61
+65.52%
8.22
Income Tax Payable
0.97
-19.32%
1.21
+34.00%
0.90
—
Current Debt And Capital Lease Obligation
20.11
+43.90%
13.97
+41.55%
9.87
-42.37%
17.13
Current Debt
12.73
+64.18%
7.76
+35.57%
5.72
-33.19%
8.56
Other Current Borrowings
12.73
+64.18%
7.76
+35.57%
5.72
-33.19%
8.56
Current Capital Lease Obligation
7.38
+18.61%
6.22
+49.80%
4.15
-51.55%
8.57
Current Deferred Liabilities
94.50
+10.35%
85.64
-7.88%
92.96
-7.65%
100.67
Current Deferred Revenue
94.50
+10.35%
85.64
-7.88%
92.96
-7.65%
100.67
Other Current Liabilities
6.13
-2.88%
6.31
+17.98%
5.35
-23.96%
7.03
Total Non Current Liabilities Net Minority Interest
196.49
-13.92%
228.28
+0.60%
226.92
+7.65%
210.80
Long Term Debt And Capital Lease Obligation
156.27
-20.58%
196.77
+0.82%
195.16
+7.02%
182.36
Long Term Debt
123.79
-24.70%
164.40
-4.17%
171.56
-0.20%
171.91
Long Term Capital Lease Obligation
32.48
+0.34%
32.37
+37.16%
23.60
+125.79%
10.45
Non Current Deferred Liabilities
26.57
+10.17%
24.11
-10.95%
27.08
+9.66%
24.69
Non Current Deferred Revenue
26.57
+10.17%
24.11
-10.95%
27.08
+9.66%
24.69
Other Non Current Liabilities
5.16
-30.17%
7.39
+58.05%
4.67
+24.73%
3.75
Stockholders Equity
81.17
+80.04%
45.08
-15.98%
53.66
+0.88%
53.19
Common Stock Equity
81.17
+80.04%
45.08
-15.98%
53.66
+0.88%
53.19
Capital Stock
0.11
+13.00%
0.10
+3.09%
0.10
+3.19%
0.09
Common Stock
0.11
+13.00%
0.10
+3.09%
0.10
+3.19%
0.09
Preferred Stock
—
—
0.00
0.00
Share Issued
103.01
+2.81%
100.19
+3.79%
96.53
+3.25%
93.50
Ordinary Shares Number
112.64
+12.42%
100.19
+3.79%
96.53
+3.25%
93.50
Additional Paid In Capital
602.16
+6.22%
566.89
+2.09%
555.28
+2.22%
543.21
Retained Earnings
-519.27
-0.31%
-517.68
-3.10%
-502.14
-1.95%
-492.52
Gains Losses Not Affecting Retained Earnings
-1.84
+56.49%
-4.22
-1100.47%
0.42
-82.46%
2.41
Other Equity Adjustments
-1.84
+56.49%
-4.22
-1100.47%
0.42
-82.46%
2.41
Total Equity Gross Minority Interest
81.17
+80.04%
45.08
-15.98%
53.66
+0.88%
53.19
Total Capitalization
204.96
-2.16%
209.48
-6.99%
225.22
+0.06%
225.10
Working Capital
124.89
-2.41%
127.97
-8.20%
139.40
-1.86%
142.03
Invested Capital
217.69
+0.21%
217.24
-5.93%
230.94
-1.16%
233.66
Total Debt
176.38
-16.31%
210.75
+2.79%
205.04
+2.78%
199.49
Net Debt
79.10
-23.63%
103.59
+17.87%
87.88
-4.20%
91.73
Capital Lease Obligations
39.86
+3.28%
38.59
+39.05%
27.75
+45.91%
19.02
Net Tangible Assets
23.35
+284.64%
-12.65
-198.84%
-4.23
+13.65%
-4.90
Tangible Book Value
23.35
+284.64%
-12.65
-198.84%
-4.23
+13.65%
-4.90
Current Provisions
3.58
-41.09%
6.08
+80.71%
3.36
-28.68%
4.72
Derivative Product Liabilities
8.50
—
—
—
Interest Payable
0.97
+99.38%
0.48
+7.06%
0.45
—
Investmentsin Joint Venturesat Cost
4.61
-53.06%
9.83
-35.05%
15.13
+9.00%
13.88
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
2.86
+124.03%
-11.90
-176.61%
15.54
+747.46%
-2.40
Cash Flow From Continuing Operating Activities
2.86
+124.03%
-11.90
-176.61%
15.54
+747.46%
-2.40
Net Income From Continuing Operations
-1.59
+89.77%
-15.54
-67.51%
-9.28
-73.56%
-5.35
Depreciation Amortization Depletion
6.15
+4.15%
5.91
+30.44%
4.53
-17.88%
5.51
Depreciation And Amortization
6.15
+4.15%
5.91
+30.44%
4.53
-17.88%
5.51
Other Non Cash Items
2.06
+115.18%
0.95
+3.13%
0.93
+13.34%
0.82
Stock Based Compensation
10.20
+7.56%
9.48
-5.66%
10.05
-5.16%
10.60
Provisionand Write Offof Assets
-0.10
+78.91%
-0.48
-120.92%
2.29
+760.90%
0.27
Asset Impairment Charge
2.22
-63.20%
6.02
+37.83%
4.37
+25.62%
3.48
Deferred Tax
0.16
-88.87%
1.40
+207.46%
0.46
-74.45%
1.78
Deferred Income Tax
0.16
-88.87%
1.40
+207.46%
0.46
-74.45%
1.78
Operating Gains Losses
1.98
-12.57%
2.26
+193.20%
-2.42
-178.56%
3.09
Gain Loss On Investment Securities
0.50
—
—
—
Gain Loss On Sale Of PPE
—
0.01
+108.15%
-0.14
-582.14%
0.03
Change In Working Capital
-18.20
+16.92%
-21.91
-573.89%
4.62
+120.46%
-22.60
Change In Receivables
13.36
+184.39%
-15.83
-185.60%
18.49
+247.68%
-12.52
Changes In Account Receivables
13.36
+184.39%
-15.83
-185.60%
18.49
+247.68%
-12.52
Change In Inventory
-9.11
-127.84%
-4.00
+41.68%
-6.86
+70.01%
-22.86
Change In Prepaid Assets
-2.54
-141.56%
6.12
+251.80%
-4.03
+33.32%
-6.04
Change In Payables And Accrued Expense
-24.58
-2961.47%
0.86
-77.01%
3.74
-79.65%
18.36
Change In Accrued Expense
-5.91
+64.22%
-16.51
-1960.88%
0.89
-86.73%
6.68
Change In Payable
-18.67
-207.54%
17.36
+509.30%
2.85
-75.59%
11.68
Change In Account Payable
-18.67
-207.54%
17.36
+509.30%
2.85
-75.59%
11.68
Change In Other Working Capital
4.05
+143.21%
-9.38
-46.70%
-6.39
-576.45%
1.34
Change In Other Current Liabilities
0.62
+93.15%
0.32
+199.07%
-0.32
+63.18%
-0.88
Investing Cash Flow
-8.52
-136.68%
-3.60
+71.60%
-12.68
-168.84%
-4.72
Cash Flow From Continuing Investing Activities
-8.52
-136.68%
-3.60
+71.60%
-12.68
-168.84%
-4.72
Net PPE Purchase And Sale
-4.27
-18.63%
-3.60
+71.45%
-12.61
-167.42%
-4.72
Purchase Of PPE
-4.27
-18.63%
-3.60
+71.45%
-12.61
-167.42%
-4.72
Capital Expenditure
-8.52
-136.68%
-3.60
+71.60%
-12.68
-168.84%
-4.72
Capital Expenditure Reported
-4.25
—
—
—
Net Business Purchase And Sale
—
—
0.00
0.00
Purchase Of Business
—
—
0.00
0.00
Net Intangibles Purchase And Sale
—
0.00
+100.00%
-0.07
0.00
Purchase Of Intangibles
—
0.00
+100.00%
-0.07
0.00
Financing Cash Flow
-4.25
-7.62%
-3.95
-87.07%
-2.11
+86.26%
-15.37
Cash Flow From Continuing Financing Activities
-4.25
-7.62%
-3.95
-87.07%
-2.11
+86.26%
-15.37
Net Issuance Payments Of Debt
7.50
+225.00%
-6.00
-55.24%
-3.87
+79.66%
-19.00
Issuance Of Debt
177.00
+3440.00%
5.00
+0.00%
5.00
0.00
Repayment Of Debt
-169.50
-1440.91%
-11.00
-24.08%
-8.87
+53.34%
-19.00
Long Term Debt Issuance
177.00
+3440.00%
5.00
+0.00%
5.00
0.00
Long Term Debt Payments
-169.50
-1440.91%
-11.00
-24.08%
-8.87
+53.34%
-19.00
Net Long Term Debt Issuance
7.50
+225.00%
-6.00
-55.24%
-3.87
+79.66%
-19.00
Short Term Debt Issuance
—
—
5.00
0.00
Short Term Debt Payments
—
—
0.00
+100.00%
-15.00
Net Short Term Debt Issuance
—
—
5.00
+133.33%
-15.00
Net Common Stock Issuance
1.63
-27.59%
2.25
+2.14%
2.20
-43.43%
3.89
Common Stock Payments
—
—
0.00
0.00
Repurchase Of Capital Stock
—
—
0.00
0.00
Proceeds From Stock Option Exercised
—
—
—
3.89
Net Other Financing Charges
-13.38
-6657.07%
-0.20
+55.70%
-0.45
-73.26%
-0.26
Changes In Cash
-9.91
+49.04%
-19.46
-2708.04%
0.75
+103.32%
-22.49
Effect Of Exchange Rate Changes
1.66
+222.38%
-1.35
-548.34%
0.30
+105.43%
-5.56
Beginning Cash Position
70.39
-22.82%
91.20
+1.16%
90.15
-23.73%
118.20
End Cash Position
62.13
-11.73%
70.39
-22.82%
91.20
+1.16%
90.15
Free Cash Flow
-5.66
+63.48%
-15.51
-642.51%
2.86
+140.16%
-7.12
Interest Paid Supplemental Data
9.74
-7.44%
10.52
+6.83%
9.85
+31.96%
7.46
Income Tax Paid Supplemental Data
3.87
+121.27%
1.75
-18.65%
2.15
+53.79%
1.40
Common Stock Issuance
1.63
-27.59%
2.25
+2.14%
2.20
-43.43%
3.89
Earnings Losses From Equity Investments
2.95
+30.62%
2.26
+198.69%
-2.29
-174.86%
3.06
Issuance Of Capital Stock
1.63
-27.59%
2.25
+2.14%
2.20
-43.43%
3.89
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category